Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: NSCLC Interventions: Drug: Kanglaite Injection+Chemotherapy; Drug: Chemotherapy Sponsors: Jie Li; Ministry of Science and Technology of the People´s Republic of China; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Chemotherapy | China Health | Clinical Trials | Lung Cancer | Non-Small Cell Lung Cancer | Research | Science